Xu Z - Search Results

1

RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4.

Wang C, Chen Z, Yi Y, Ding Y, Xu F, Kang H, Lin K, Shu X, Zhong Z, Zhang Z, Liu J, Xu Z, Liu L, He X, Chang Y, Zhao Q. Wang C, et al. Among authors: xu f, xu z. Oncogene. 2024 Jan;43(5):328-340. doi: 10.1038/s41388-023-02902-4. Epub 2023 Dec 1. Oncogene. 2024. PMID: 38040804

2

β-Catenin signaling in hepatocellular carcinoma.

Xu C, Xu Z, Zhang Y, Evert M, Calvisi DF, Chen X. Xu C, et al. Among authors: xu z. J Clin Invest. 2022 Feb 15;132(4):e154515. doi: 10.1172/JCI154515. J Clin Invest. 2022. PMID: 35166233 Free PMC article. Review.

3

Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice.

Wang J, Dong M, Xu Z, Song X, Zhang S, Qiao Y, Che L, Gordan J, Hu K, Liu Y, Calvisi DF, Chen X. Wang J, et al. Among authors: xu z. Oncogene. 2018 Jun;37(24):3229-3242. doi: 10.1038/s41388-018-0188-1. Epub 2018 Mar 16. Oncogene. 2018. PMID: 29545603 Free PMC article.

4

The mTORC2-Akt1 Cascade Is Crucial for c-Myc to Promote Hepatocarcinogenesis in Mice and Humans.

Xu Z, Xu M, Liu P, Zhang S, Shang R, Qiao Y, Che L, Ribback S, Cigliano A, Evert K, Pascale RM, Dombrowski F, Evert M, Chen X, Calvisi DF, Chen X. Xu Z, et al. Among authors: xu m. Hepatology. 2019 Nov;70(5):1600-1613. doi: 10.1002/hep.30697. Epub 2019 Jun 21. Hepatology. 2019. PMID: 31062368 Free PMC article.

5

Loss of Pten synergizes with c-Met to promote hepatocellular carcinoma development via mTORC2 pathway.

Xu Z, Hu J, Cao H, Pilo MG, Cigliano A, Shao Z, Xu M, Ribback S, Dombrowski F, Calvisi DF, Chen X. Xu Z, et al. Among authors: xu m. Exp Mol Med. 2018 Jan 5;50(1):e417. doi: 10.1038/emm.2017.158. Exp Mol Med. 2018. PMID: 29303510 Free PMC article.

6

Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans.

Li L, Che L, Tharp KM, Park HM, Pilo MG, Cao D, Cigliano A, Latte G, Xu Z, Ribback S, Dombrowski F, Evert M, Gores GJ, Stahl A, Calvisi DF, Chen X. Li L, et al. Among authors: xu z. Hepatology. 2016 Jun;63(6):1900-13. doi: 10.1002/hep.28508. Epub 2016 Mar 25. Hepatology. 2016. PMID: 26910791 Free PMC article.

7

Focal adhesion kinase activation limits efficacy of Dasatinib in c-Myc driven hepatocellular carcinoma.

Liu X, Song X, Zhang J, Xu Z, Che L, Qiao Y, Ortiz Pedraza Y, Cigliano A, Pascale RM, Calvisi DF, Liu Y, Chen X. Liu X, et al. Among authors: xu z. Cancer Med. 2018 Dec;7(12):6170-6181. doi: 10.1002/cam4.1777. Epub 2018 Oct 28. Cancer Med. 2018. PMID: 30370649 Free PMC article.

8

Bmi1 drives the formation and development of intrahepatic cholangiocarcinoma independent of Ink4A/Arf repression.

Guo J, Deng N, Xu Y, Li L, Kuang D, Li M, Li X, Xu Z, Xiang M, Xu C. Guo J, et al. Among authors: xu c, xu y, xu z. Pharmacol Res. 2021 Feb;164:105365. doi: 10.1016/j.phrs.2020.105365. Epub 2020 Dec 8. Pharmacol Res. 2021. PMID: 33307220

9

SNP rs2596542G>A in MICA is associated with risk of hepatocellular carcinoma: a meta-analysis.

Wang H, Cao H, Xu Z, Wang D, Zeng Y. Wang H, et al. Among authors: xu z. Biosci Rep. 2019 May 7;39(5):BSR20181400. doi: 10.1042/BSR20181400. Print 2019 May 31. Biosci Rep. 2019. PMID: 30967497 Free PMC article.

10

mTORC2 Signaling Is Necessary for Timely Liver Regeneration after Partial Hepatectomy.

Xu M, Wang H, Wang J, Burhan D, Shang R, Wang P, Zhou Y, Li R, Liang B, Evert K, Utpatel K, Xu Z, Song X, Che L, Calvisi DF, Wang B, Chen X, Zeng Y, Chen X. Xu M, et al. Among authors: xu z. Am J Pathol. 2020 Apr;190(4):817-829. doi: 10.1016/j.ajpath.2019.12.010. Epub 2020 Feb 5. Am J Pathol. 2020. PMID: 32035060 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35,654 results

Search Page